By Abigail Townsend
Date: Monday 18 Mar 2019
(Sharecast News) - Shares in Nasdaq's Dermira have more than doubled after the biopharmaceutical company unveiled positive trials for a possible new eczema treatment.
No recent information was found.
Currency | US Dollars |
Share Price | $ 7.47 |
Change Today | $ 0.39 |
% Change | 5.51 % |
52 Week High | $7.87 |
52 Week Low | $3.66 |
Volume | 239,603 |
Shares Issued | 53.67m |
Market Cap | $400.90m |
Beta | 0.16 |
Time | Volume / Share Price |
16:00 | 7,480 @ $7.47 |
15:59 | 100 @ $7.48 |
15:59 | 200 @ $7.48 |
15:59 | 100 @ $7.48 |
15:59 | 100 @ $7.48 |
You are here: research